Antioxidant stress and anticancer activity of peptide‑chelated selenium in vitro

Int J Mol Med. 2021 Aug;48(2):153. doi: 10.3892/ijmm.2021.4986. Epub 2021 Jun 24.

Abstract

The association between selenium and peptide in gastric cancer is an important research topic. The present study reported the facile synthesis of anticancer bioactive peptide (ACBP)‑functionalized selenium (ACBP‑S‑Se) particles with enhanced anticancer activities and a detailed mechanistic evaluation of their ability to regulate oxidative stress in vitro. Structural and chemical characterizations were revealed by ultraviolet absorption, Fourier transform infrared, X‑ray photoelectron, nuclear magnetic resonance carbon and hydrogen, energy dispersive X‑ray spectroscopy and inductively coupled plasma mass spectrometry, as well as scanning electron microscopy. Sulfhydrylation modifications of ACBP were achieved with S‑acetylmercaptosuccinic anhydride via chemical absorption. After the polypeptide was modified by sulfhydrylation, the ACBP chain was linked to sulfhydryl groups by amide bonds to form the ACBP‑chelated selenium complex. Two gastric cancer cell lines (MKN‑45 and MKN‑74 cells) demonstrated high susceptibility to ACBP‑S‑Se particles and displayed significantly decreased proliferation ability following treatment. The results suggested that the bioactive peptide‑chelated selenium particles effectively inhibited the proliferation of MKN‑45 and MKN‑74 cells in vitro. The genes encoding CDK inhibitor 1A (CDKN1A), cyclin B1, thioredoxin (TXN) and mitogen‑activated protein kinase kinase kinase 5 are associated with regulation of oxidative stress, while CDKN1A and TXN protect cells by decreasing oxidative stress and promoting cell growth arrest. Therefore, ACBP‑S‑Se may be an ideal chemotherapeutic candidate for human cancer, especially gastric cancer.

Keywords: anticancer bioactive peptide; antitumor agent; gastric cancer; selenium element.

MeSH terms

  • Antineoplastic Agents / chemistry
  • Antineoplastic Agents / pharmacology*
  • Antioxidants / pharmacology*
  • Cell Line
  • Cell Line, Tumor
  • Cell Movement / drug effects
  • Cell Movement / genetics
  • Cell Proliferation / drug effects
  • Cell Proliferation / genetics
  • Cyclin B1 / genetics
  • Cyclin-Dependent Kinase Inhibitor p21 / genetics
  • Gene Expression Profiling / methods
  • Gene Expression Regulation, Neoplastic / drug effects
  • Gene Ontology
  • Gene Regulatory Networks
  • Humans
  • MAP Kinase Kinase Kinase 5 / genetics
  • Oxidative Stress / drug effects*
  • Peptides / chemistry
  • Peptides / pharmacology*
  • Selenium / chemistry
  • Selenium / pharmacology*
  • Stomach Neoplasms / genetics*
  • Stomach Neoplasms / metabolism
  • Stomach Neoplasms / pathology
  • Thioredoxins / genetics

Substances

  • Antineoplastic Agents
  • Antioxidants
  • CDKN1A protein, human
  • Cyclin B1
  • Cyclin-Dependent Kinase Inhibitor p21
  • Peptides
  • Thioredoxins
  • MAP Kinase Kinase Kinase 5
  • MAP3K5 protein, human
  • Selenium

Grants and funding

The present study was supported by the National Natural Science Foundation of China (grant nos. 81860416 and 81660468), General Project and Doctor starts of affiliated Hospital of Inner Mongolia Medical University (grant nos. NYFY YB044 and NYFY BS 2018), Inner Mongolia Autonomous Region University 'Youth Science and Technology Talent Support Program' (grant no. NJYT-20-B17) and Scientific and Technological Innovation of College Students in Inner Mongolia Medical University 2020 Project Task of 'Cultivation of Excellence' Project (grant no. YCPY20200033) and Laboratory Open Projects (grant no. 2020ZN47).